# Understanding the Properties and Utility of PKCε Inhibitor PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … Peptide
In the specialized field of biochemical research, the study of sign This peptide specifically inhibits epsilon-PKC by disrupting PKC binding to its receptor, RACK2. epsilonPKC mediated signal … al transduction path PRKCE - Wikipedia ways remains a cornerstone for understanding cellular dynamics. Among the various tools available to researchers, the PKCε inhibitor peptide—often referred to by the synonym εV1-2—stands out as a sophisticated instrument for modulating specific protein activities. As someone who follows peptide science closely, I find the structural precision of these compounds fascinating.
The PKCε inhibitor peptide (CAS Nu This peptide specifically inhibits epsilon-PKC by disrupting PKC binding to its receptor, RACK2. epsilonPKC mediated signal … mber: 182683-50-7) is a selective octapeptide derived from the protein kinase C epsilon (PKCε) isoform itself. Its primary function is to act as a translocation inhibitor. By targeting the interaction between the isozyme and its receptor for activated C kinase (RACK2), this peptide effectively prevents the enzyme from migrating to its subcellular docking sites.
When researchers discuss what is PKCε inhibitor peptide, they are often referring to the sequence EAVSLKPT. This sequence, when engineered as a myristoylated version (Myr-PKCε), gains enhanced cell permeability, allowing it to PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … penetrate cell membranes effectively during *in vitro* and *in vivo* laboratory investigat Dec 15, 2023 · Human protein kinases are highly-sought-after drug targets, historically harnessed for treating cancer, cardiovascular … ions.
Mechanism and Specificity
The specificity of this peptide is its most remarkable asset. Because it targets the C2 domain of the PKCε protein (specifically amino acids 14–21), it avoids cross-reactivity with other PKC isozymes. This selective inhibition is crucial for scientists aiming to map out the precise roles of PKCε in intracellular signaling.
For those curious about how does PKCε inhibitor peptide work, the mechanism is elegant in its simplicity:
1. Binding: The peptide acts as a competitive antagonist, binding to the RACK2 docking site.
2. Disruption: By occupying the site, it physically prevents the native PKCε from docking.
3. Reversibility: The action is reversible, allowing for controlled biological study over specific time windows during experimental observation.
Applications and Research Context
The application of this peptide spans a wide range of academic inquiries. Researchers often utilize it to explore kinase signaling pathways. When assessing the effectiveness of PKCε inhibitor peptide, one must consider its purity and storage conditions. Most laboratory-grade samples are provided as lyophilized powders; upon reconstitution, they must be handled carefully to maintain structural integrity.
The integration of these peptides into experimental workflows is often contrasted with other tools. For instance, comparing the PKCε inhibitor peptide vs. other PKC inhibitors highlights the difference between generalized kinase inhibition and the highly localized, domain-specific inhibition that εV1-2 provides.
Important Technical Considerations
* Structure: It is an octapeptide with the sequence H-Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr-OH.
* Controls: In well-designed experiments, a negative control peptide is often used alongside the active inhibitor to ensure that observed cellular responses are specific to the inhibition of the PKCε-RACK pathway.
* Delivery: The use of myristoylation or conjugation with cell-penetrating sequences like TAT is standard practice to overcome the natural barriers of the cell membrane.
Exploring the Broader Field
In the scientific community, the search for robust biochemical tools persists. When evaluating the safety of PKCε inhibitor peptide, it is strictly intended for inter An octapeptide that selectively inhibits the translocation of protein kinase C ε to subcellular sites in a reversible manner. Inhibition of … nal research use only. The community is constantly seeing new developments in PKCε inhibitors, including bifunctional designs that merge two distinct technologies to enhance cellular PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … targeting.
For those interested in the significance of PKCε translocation inhibition, the literature emphasizes that the ability to intercept a kinase before it reaches its target site—rather than simply inhibiting its catalytic activity—offers a cleaner look at signal cascades. This distinction is vital when performing western blots or immunofluorescence studies to visualize translocation patterns.
Final Reflections
My observation of the developments in this sector suggests that the precision of peptide-based tools is only increasing. The PKCε inhibitor peptide represents a gold standard for specificity in targeted signaling disruption. As we continue to refine our methods, the focus remains on the structural design and the fidelity of the molecular interactions, ensuring that every research output is backed by high-quality, verifiable chemical entities.
Whether you are investigating the C2 domain interactions or mapping the role of RACK2, the εV1-2 peptide remains an indispensable reference point in the modern molecular toolbox. Always ensure your source material provides comprehensive analytical data, such as HPLC and mass spectrometry result PKCε inhibitor peptide,myristoylated (Myr‐PKCɛ-) | PKCε抑制剂 | MCE s, to verify the identity and purity of the compound.
# Understanding the Properties and Utility of PKCε Inhibitor PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … Peptide
In the specialized field of biochemical research, the study of sign This peptide specifically inhibits epsilon-PKC by disrupting PKC binding to its receptor, RACK2. epsilonPKC mediated signal … al transduction path PRKCE - Wikipedia ways remains a cornerstone for understanding cellular dynamics. Among the various tools available to researchers, the PKCε inhibitor peptide—often referred to by the synonym εV1-2—stands out as a sophisticated instrument for modulating specific protein activities. As someone who follows peptide science closely, I find the structural precision of these compounds fascinating.
The PKCε inhibitor peptide (CAS Nu This peptide specifically inhibits epsilon-PKC by disrupting PKC binding to its receptor, RACK2. epsilonPKC mediated signal … mber: 182683-50-7) is a selective octapeptide derived from the protein kinase C epsilon (PKCε) isoform itself. Its primary function is to act as a translocation inhibitor. By targeting the interaction between the isozyme and its receptor for activated C kinase (RACK2), this peptide effectively prevents the enzyme from migrating to its subcellular docking sites.
When researchers discuss what is PKCε inhibitor peptide, they are often referring to the sequence EAVSLKPT. This sequence, when engineered as a myristoylated version (Myr-PKCε), gains enhanced cell permeability, allowing it to PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … penetrate cell membranes effectively during *in vitro* and *in vivo* laboratory investigat Dec 15, 2023 · Human protein kinases are highly-sought-after drug targets, historically harnessed for treating cancer, cardiovascular … ions.
Mechanism and Specificity
The specificity of this peptide is its most remarkable asset. Because it targets the C2 domain of the PKCε protein (specifically amino acids 14–21), it avoids cross-reactivity with other PKC isozymes. This selective inhibition is crucial for scientists aiming to map out the precise roles of PKCε in intracellular signaling.
For those curious about how does PKCε inhibitor peptide work, the mechanism is elegant in its simplicity:
1. Binding: The peptide acts as a competitive antagonist, binding to the RACK2 docking site.
2. Disruption: By occupying the site, it physically prevents the native PKCε from docking.
3. Reversibility: The action is reversible, allowing for controlled biological study over specific time windows during experimental observation.
Applications and Research Context
The application of this peptide spans a wide range of academic inquiries. Researchers often utilize it to explore kinase signaling pathways. When assessing the effectiveness of PKCε inhibitor peptide, one must consider its purity and storage conditions. Most laboratory-grade samples are provided as lyophilized powders; upon reconstitution, they must be handled carefully to maintain structural integrity.
The integration of these peptides into experimental workflows is often contrasted with other tools. For instance, comparing the PKCε inhibitor peptide vs. other PKC inhibitors highlights the difference between generalized kinase inhibition and the highly localized, domain-specific inhibition that εV1-2 provides.
Important Technical Considerations
* Structure: It is an octapeptide with the sequence H-Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr-OH.
* Controls: In well-designed experiments, a negative control peptide is often used alongside the active inhibitor to ensure that observed cellular responses are specific to the inhibition of the PKCε-RACK pathway.
* Delivery: The use of myristoylation or conjugation with cell-penetrating sequences like TAT is standard practice to overcome the natural barriers of the cell membrane.
Exploring the Broader Field
In the scientific community, the search for robust biochemical tools persists. When evaluating the safety of PKCε inhibitor peptide, it is strictly intended for inter An octapeptide that selectively inhibits the translocation of protein kinase C ε to subcellular sites in a reversible manner. Inhibition of … nal research use only. The community is constantly seeing new developments in PKCε inhibitors, including bifunctional designs that merge two distinct technologies to enhance cellular PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … targeting.
For those interested in the significance of PKCε translocation inhibition, the literature emphasizes that the ability to intercept a kinase before it reaches its target site—rather than simply inhibiting its catalytic activity—offers a cleaner look at signal cascades. This distinction is vital when performing western blots or immunofluorescence studies to visualize translocation patterns.
Final Reflections
My observation of the developments in this sector suggests that the precision of peptide-based tools is only increasing. The PKCε inhibitor peptide represents a gold standard for specificity in targeted signaling disruption. As we continue to refine our methods, the focus remains on the structural design and the fidelity of the molecular interactions, ensuring that every research output is backed by high-quality, verifiable chemical entities.
Whether you are investigating the C2 domain interactions or mapping the role of RACK2, the εV1-2 peptide remains an indispensable reference point in the modern molecular toolbox. Always ensure your source material provides comprehensive analytical data, such as HPLC and mass spectrometry result PKCε inhibitor peptide,myristoylated (Myr‐PKCɛ-) | PKCε抑制剂 | MCE s, to verify the identity and purity of the compound.